MB, Levis & Associates
CVS icon

MB, Levis & Associates’s CVS Health CVS Stock Holding History

MB, Levis & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.7K Buy
323
+2
+0.6% +$196 0.01% 131
2026
Q2 		$33.2K Buy
321
+2
+0.6% +$179 0.01% 128
2026
Q1 		$22.9K Buy
319
+3
+0.9% +$231 0.01% 136
2025
Q4 		$25.1K Buy
316
+3
+1% +$237 0.01% 133
2025
Q3 		$23.6K Buy
313
+3
+1% +$206 0.01% 134
2025
Q2 		$21.4K Buy
310
+3
+1% +$197 0.01% 165
2025
Q1 		$20.8K Buy
307
+3
+1% +$180 0.01% 160
2024
Q4 		$13.6K Buy
304
+4
+1% +$224 0.01% 175
2024
Q3 		$18.9K Sell
300
-328
-52% -$19.1K 0.01% 164
2024
Q2 		$37.1K Buy
628
+7
+1% +$438 0.02% 127
2024
Q1 		$49.5K Sell
621
-13
-2% -$993 0.03% 118
2023
Q4 		$50.1K Buy
634
+5
+0.8% +$356 0.03% 115
2023
Q3 		$43.9K Buy
629
+24
+4% +$1.7K 0.03% 117
2023
Q2 		$41.8K Buy
605
+5
+0.8% +$356 0.03% 126
2023
Q1 		$44.6K Hold
600
– – 0.03% 116
2022
Q4 		$55.9K Buy
+600
New +$57.9K 0.04% 100

Other funds holding CVS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

MB, Levis & Associates's CVS Position: Q3 2026 in Review

MB, Levis & Associates increased its CVS Health (CVS) stake by 0.62% in Q3 2026, buying an estimated $196 and bringing the position to 323 shares worth $27.7K. The position accounts for 0.01% of the portfolio, ranked #131.

MB, Levis & Associates first reported a position in CVS in Q4 2022 and has held it in 16 quarters since. The position peaked at $55.9K in Q4 2022. 953 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • MB, Levis & Associates held 323 shares of CVS Health worth $27.7K as of Q3 2026.
  • MB, Levis & Associates bought 2 CVS Health shares in Q3 2026, an estimated $196.
  • CVS Health made up 0.01% of MB, Levis & Associates's portfolio in Q3 2026, its #131 holding.
  • MB, Levis & Associates first reported a position in CVS Health in Q4 2022 and has held it in 16 quarters since.
  • MB, Levis & Associates's CVS Health position peaked at $55.9K in Q4 2022.
  • 953 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.